July 27, 2021
Moyamoya disease is one of the most common causes of pediatric stroke
Stroke, a devastating condition that causes damage to the brain due to interruption of blood supply, is often considered an adult disease. But children can experience strokes as well. Sadly, pediatric stroke affects one in every 4,000 newborns and an additional 2,000 older children each year.
The most common cause of stroke in children is moyamoya disease (MMD), a rare condition where the brain’s arteries progressively narrow. While this disease affects people mostly from east Asian backgrounds, especially those of Japanese descent, it develops in children from other backgrounds as well.
TN-RDAC To Inform TennCARE On Pharmaceutical Treatments Wednesday, May 12, 2021 The newly formed Tennessee Rare Disease Advisory Council or TN-RDAC (pronounced AHR-dak) has set its priorities to advocate for Tennesseans diagnosed with rare diseases, including advising TennCare’s Pharmacy Advisory Committee and Drug Utilization Review Committee on pharmaceutical treatments, as well as identifying the overall impact of rare diseases on Tennesseans. Created by public charter in the 111th Tennessee General Assembly, TN-RDAC elected at its inaugural meeting its Chairman Dr. Scott Strome, executive dean of the University of Tennessee College of Medicine and vice chancellor for clinical affairs at UT Health Science Center. Dr. Strome brings rare disease research and clinical experience to the TN-RDAC.
Share this article
Share this article
BETHESDA, Md., April 12, 2021 /PRNewswire/ The American College of Medical Genetics and Genomics (ACMG) welcomed five new directors, including a new president-elect, to its Board of Directors at the 2021 ACMG Annual Clinical Genetics Meeting – A Virtual Experience. The new Board members will serve as advocates for the organization and will assist in shaping and implementing the mission, vision, and direction of the College. The five newly elected directors will serve six-year terms from April 2021 to March 2027. I have enjoyed the chance to meet our recently elected Board members. Each of them offers unique perspectives, new insights and opportunities to advance ACMG s strategic plan, said Anthony Gregg, MD, MBA, FACMG, president of the ACMG. I hope every ACMG member feels comfortable reaching out to the Board with the goal of moving our strategic plan forward. There are many ways to plug in.
Researchers say static electromagnetic fields (EMFs) could be a non-invasive and safe way of managing blood glucose in diabetes.
By exposing diabetic mice to a combination of electromagnetic fields (EMFs) for a relatively short period, the animal models’ blood glucose has been reduced and bodies’ response to insulin normalized, according to Calvin Carter, Ph. D., one of the study’s lead authors and a post-doctoral candidate of the UI Carver College of Medicine, Division of Medical Genetics and Genomics.
Because of this unexpected and surprising discovery about EMFs, treatment modalities for Type 2 Diabetes Mellitus (T2DM) can be revolutionized, especially for patients who find current treatment guidelines arduous, paving the way for significant diabetes care implications and management.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Amicus Therapeutics Announces Presentations and Posters at the 17th Annual WORLDSymposium™ 2021
Amicus Therapeutics, Inc.January 21, 2021 GMT
CRANBURY, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that three oral presentations and ten posters highlighting its development programs for Lysosomal Disorders will be included at the 17th Annual WORLD
Symposium ™ 2021, to be held virtually February 8-12, 2021.
ADVERTISEMENT
Oral Platform Presentations:
Direct intercellular cross-correction of α-galactosidase-A deficiency in Fabry disease podocytes through tunneling nanotubes in a mixed cell culture model – Behzad Najafian, MD, Department of Pathology, University of Washington, Seattle, WA, USA (Monday, F